Given Imaging Ltd announced that the FDA has granted 510(k) clearance for the next-generation PillCam, SB 3, to detect and monitor small bowel abnormalities associated with Crohn’s disease, obscure gastrointestinal (GI) bleeding, and iron deficiency anemia.
The PillCam SB 3 system combines a 30% improvement in image resolution with adaptive frame rate technology to deliver more detailed small bowel images and coverage. In addition, PillCam SB 3’s video processing engine has been significantly improved. Proprietary algorithms in the system’s new software enable even smarter video compilation that is 40% more efficient than PillCam SB 2.
